A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2001
11/14/2001	EP0885212B1 Quinoxalinediones
11/14/2001	EP0862431B1 Use of a paediatric pharmaceutical formulation comprising amoxycillin and clavulanate
11/14/2001	EP0850246B1 Pyrimidine nucleoside derivatives
11/14/2001	EP0832077B1 Improved isoxazoline fibrinogen receptor antagonists
11/14/2001	EP0828721B1 2-amino-benzoxazinones for the treatment of viral infections
11/14/2001	EP0827500B1 (2-morpholinylmethyl)benzamide derivatives
11/14/2001	EP0815087B1 Trisubstituted phenyl derivatives
11/14/2001	EP0812198B1 Stabilization of prostaglandin compositions
11/14/2001	EP0804170B1 Method for making freeze dried drug dosage forms
11/14/2001	EP0777482B1 Combined preparation for the therapy of immune diseases
11/14/2001	EP0771555B1 Agent for external application with nutrient and protective properties
11/14/2001	EP0763037B1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF
11/14/2001	EP0762883B1 Pyridylbisphosphonates for use as a therapeutical agent
11/14/2001	EP0760648B1 Chewable flubendazole tablets for companion animals
11/14/2001	EP0728763B1 Ganglioside gm3 analog having sialic acid residue fluorinated at the 9-position and intermediate therefor
11/14/2001	EP0722322B1 Compounds, compositions and treatment of allergies and inflammation therewith
11/14/2001	EP0713527B1 Fungicidal methods and compositions for killing yeast and sporular microorganisms
11/14/2001	EP0675882B1 5-aryl-1,3-thiazine derivatives, manufacture thereof and use as pesticides
11/14/2001	EP0672041B1 Pharmacologically active pyridine derivatives and processes for the preparation thereof
11/14/2001	EP0652948B1 Development of a vector to target gene expression to the epidermis of transgenic animals
11/14/2001	CN1322246A Restin and methods of use thereof
11/14/2001	CN1322244A Tumor necrosis factor-gamma
11/14/2001	CN1322210A High purity composition comprising (7a, 17a,)-17-hydroxy-7-methyl 19-nor-17-prege-5-(10)-en-20-yn-3-one
11/14/2001	CN1322209A Flavonoids derived from citrus peels as collagen-induced platelet aggregation inhibitor
11/14/2001	CN1322206A Naphtho- and dihydrobenzo-thiopyhene derivatives as cytotoxic antitumor agents
11/14/2001	CN1322205A Derivatives of isosorbid mononitrate, utilization as vasodilator agents with reduced tolerance
11/14/2001	CN1322204A Oxazolidinone antibacterial agents having thiocarbonyl functionality
11/14/2001	CN1322203A Heterocyclyl amino methyloxazolidinones as antibacterials
11/14/2001	CN1322202A Quinazoline derivatives
11/14/2001	CN1322201A Improved omeprazole process and compositions thereof
11/14/2001	CN1322200A Enantioselective synthesis
11/14/2001	CN1322198A HIV replication inhibiting pyrimidines
11/14/2001	CN1322197A New 4-amino-1-aryl-pyridine-2-ones with anticonvulsive action and method for producing same
11/14/2001	CN1322196A Naphthalenecaarboxamides as tachykinin receptor antagonists
11/14/2001	CN1322194A Substituted phenyl derivatives, their preparation and use
11/14/2001	CN1322193A Unsaturated hydroximic acid derivatives as PARP inhibitors
11/14/2001	CN1322188A A process for preparation of 4,4'-dihalogen-O-hydroxydiphenyl compounds
11/14/2001	CN1322140A Stabilized preparations of beta-lactam antibiotic
11/14/2001	CN1322139A Agents for retarding change of hormone-dependent cancer into hormone-independent cancer
11/14/2001	CN1322136A Neuroimmunophilins for selective neuronal radioprotection
11/14/2001	CN1322135A Drugs for periodontal diseases
11/14/2001	CN1322134A Naphthalenecarboxamides as tachykinin receptor antagonists
11/14/2001	CN1322133A Vitronectin receptor antagonists
11/14/2001	CN1322132A Bioflavonoid as blood gloucose level lowering agent
11/14/2001	CN1322131A Nimesulide containing topical pharmaceutical compositions
11/14/2001	CN1322130A Inhibitors of type 3 3a -hydrosteroid dehydrogenase
11/14/2001	CN1322109A Hydroxystilbene compounds used as microbicidal active substances
11/14/2001	CN1321746A Human insuline recombinant gene, preparation method and application
11/14/2001	CN1321643A Nabufulin polybasic ester derivative and its production method
11/14/2001	CN1321639A Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg them
11/14/2001	CN1321638A Method for preparing methylsulfonate trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperid-1-yl)-1-propanol
11/14/2001	CN1321634A Substd heterocyclic compounds preparing method thereof and pharmaceutical composition contg. them
11/14/2001	CN1321500A Method for preventing and curing diseases by using kakonein preparation
11/14/2001	CN1321499A Chinese patent medicine for curing deafness
11/14/2001	CN1321486A Yinkang lotion
11/14/2001	CN1321483A Chinese medicine-psoralen preparation for preventing and curing hyperplasia of prostate
11/14/2001	CN1321481A Medicine for external application for treating sweaty feet with bromidrosis
11/14/2001	CN1321465A Dermatitis treating medicine
11/14/2001	CN1321464A Water soluble clomiphene preparation and its preparation method
11/14/2001	CN1321444A Composition contg. anthocyanidin
11/14/2001	CN1074767C Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
11/14/2001	CN1074766C Alkylaminobenzothiazole and -benzoxazole derivatives
11/14/2001	CN1074764C Benzoxazinone dopamine D4 receptor antagonists
11/14/2001	CN1074762C Process for preparing chromium L-threonate, its preparing process and application
11/14/2001	CN1074676C Medicine for treating rheumatic arthritis and hyperosteogeny and preparing process thereof
11/14/2001	CN1074671C Medicinal pollen for treating cancer
11/14/2001	CN1074667C Medicine for treating wound
11/14/2001	CN1074666C Folic acid supplementing agent for preventing neural tube deformity
11/14/2001	CN1074665C Method and medical agent for diagnosis and/or therapy of arthritis
11/13/2001	US6316672 Form a of fluoxetine hydrochloride
11/13/2001	US6316648 Purified 5,6,15-trihydroxy-7,9,13-trans-11-cis-eicosatetraenoic acid; anticarcinogenic and antiproliferative agents
11/13/2001	US6316642 For therapy of osteoporosis and psoriasis, as anticancer agent
11/13/2001	US6316638 Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel
11/13/2001	US6316635 Used in prophylaxis and therapy of protein kinase related cellular disorders such as cancer, diabetes, autoimmune disorder, hyperproliferation disorder, inflammatory disorder, angiogenesis, restenosis, fibrosis, psoriasis, osteoarthritis
11/13/2001	US6316630 Treating epothilone to deoxygenate the epothilone, and thereby to provide the desoxyepothilone
11/13/2001	US6316618 Process for preparing (-)pyridobenzoxazine carboxylic acid derivatives
11/13/2001	US6316617 For treating physiological disorders associated with an excess of neuropeptide y, such as feeding disorders and certain cardiovascular diseases, medical diagnosis
11/13/2001	US6316601 Antibodies specific for β6 integrins
11/13/2001	US6316504 Administering r(+)-n-propargyl-1-aminoindan or its salt for therapy of multiple sclerosis
11/13/2001	US6316503 For therapy of disease states associated with cholesterol metabolism such as atherosclerosis and hypercholesterolemia
11/13/2001	US6316502 Administering disulfide derivative of dithiocarbamate compound to bind to iron
11/13/2001	US6316501 Methods of inducing analgesia or anesthesia and treating or preventing ischemic injury of tissues in general
11/13/2001	US6316499 Administering formulation comprising asubstance or substances selected from synephrine, hordenine, synephrine, hordenine, octopamine, tyramine and n-methyltyramine for increasing muscle mass of human
11/13/2001	US6316497 For suppressing cell proliferation and neovascularization
11/13/2001	US6316495 Administering 5-iodo-6-amino-1,2-benzopyrones for inhibiting the poly-adp-ribosylation of adenosine diphosphoribosyl transferase
11/13/2001	US6316492 Methods for treating or preventing viral infections and associated diseases
11/13/2001	US6316488 Antibiotic compound
11/13/2001	US6316487 For therapy of ventricular tachyarrhythmias, especially in patients with congestive heart failure and ventricular arrhythmias and supraventricular arrhythmias, including atrial fibrillation and re-entrant tachyarrhythmias
11/13/2001	US6316485 1,5-diphenylpyrazole derivatives
11/13/2001	US6316484 Pentafluorobenzenesulfonamides and analogs
11/13/2001	US6316483 Oxymetazoline HCI and/or chlorpheniramine maleate nasal spray compositions
11/13/2001	US6316482 Benzamide derivatives having a vasopressin antagonistic activity
11/13/2001	US6316481 Pharmaceutical composition containing proton pump inhibitors
11/13/2001	US6316478 IL-8 receptor antagonists
11/13/2001	US6316474 Treatment of pain, schizophrenia, parkinson's disease, stroke and depression
11/13/2001	US6316473 Good drug release and absorption
11/13/2001	US6316472 Heterosubstituted pyridine derivatives as PDE 4 inhibitors
11/13/2001	US6316471 Treating inflammatory or autoimmune diseases
11/13/2001	US6316469 Use of selective serotonin reuptake inhibitors for treatment of chest pain of non-cardiac origin and gastro-esophageal reflux disease
11/13/2001	US6316467 Elevation of HDL cholesterol by 4-[(Aminothioxomethyl)-hydrazono]-N-(substituted)-4-arylbutanamides

1 ... 5969 5970 5971 5972 5973 5974 5975 5976 5977 5978 5979 5980 5981 5982 5983 5984 5985 5986 5987 5988 5989 ... 7860